Publications scientifiques sur le VIH
Impact of Tesamorelin on Cardiovascular Disease Risk Prediction Scores in Phase 3 Studies Treatment Arms: Subanalysis
2024
S. Grinspoon , L. Fourman , T Stanley , D. Benkeser , C. McGary , R.B. Cash
Intramuscular Injection vs Intravenous Infusion of Ibalizumab for HTE PWH: The Results of TMB-302
2024
Kaitlin R. Anstett , R. Brandon Cash , Anthony Mills, Mezgebe Berhe, Edwin DeJesus
Cardiovascular Risk Scores and Insulin Resistance Are Higher With Excess Visceral Abdominal Fat in People With Hiv in the Modern Antiretroviral Era
2024
K. MOUNZER , J.R. KOETHE , J.E. LAKE , M. ZOGHEIB , C.S. McGARY , B. CASH
Efficacy and Safety of 2 Fixed Doses of Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced HIV-Positive Individuals
2024
Edwin DeJesus, MD, William J. Towner, Jr, MD, Joseph C Gathe, MD, R. Brandon Cash, PharmD, and Kaitlin Anstett, PhD
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) Study Design and Baseline Characteristics
2024
Kumar, P. , Rolle, C., Henry, Z., Emu, B., Martorell, C., McKinnon, J., Slim, J., Cash, R. B. and Anstett, K., on behalf of the PROMISE-US Investigators